PharmStockPharmacy Stock

Pletal
Pletal

1.79
For patients managing pain and inflammation, this generic medicine widens peripheral blood vessels and limits platelet activity to ease circulation-related discomfort.
Ingredient
Cilostazol
Category
Pain & Anti-Inflammatories
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Cilostazol
Reference Brand
Cilostazol
Product Origin
Generic Alternative
Reference Manufacturer
Otsuka Pharmaceutical
Product Form
Tablet
Regulatory Classification
Prescription Only Medicine
Primary Category
Pain Relief
Product Category
Phosphodiesterase-3 (PDE3) Inhibitor
Pharmacological Class
Platelet Aggregation Inhibitor
Clinical Indications
Intermittent claudication
Manufacturer Description
Formulated to alleviate walking pain in arterial disease to support vascular expansion and target platelet activity.
Mechanism of Action
Inhibits PDE3, raising intracellular cAMP to relax vascular smooth muscles and block platelet cross-linking.
Route of Administration
Oral
Onset Time
2–4 weeks
Duration
12 hours
Contraindications
Congestive heart failure of any severity, Active pathological bleeding
Severe Adverse Events
Severe cardiac arrhythmia — requires immediate medical attention
Common Side Effects
Headache, Diarrhea, Nausea
Uncommon Side Effects
Palpitations, Dizziness, Rhinitis
Drug Interactions
Aspirin, Clopidogrel, Grapefruit
Pregnancy Safety Warnings
TGA Category C: Use only if potential benefit outweighs risk. Breastfeeding: Not recommended.
Age Restrictions
Approved for adults.
Storage Guidelines
Store below 25°C.
Information related to Pletal is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
where to order Antivirals Australia - Famvir Australia